Uncategorized Bacteriophage endolysin powders for therapy 17 Feb 2023 A new article punished in the International Journal of Pharmaceutics describes the "Bacteriophage endolysin powders for inhaled delivery against pulmonary infections" by Wang et al. https://doi.org/10.1016/j.ijpharm.2023.122679 Abstract Endolysins are bacteriophage-encoded…
Uncategorized Targeting Phage Therapy 2023 13 Feb 2023 The 6th World Congress on Targeting Phage Therapy 2023 will take place on June 1-2 at IRIS, Paris, France. Targeting Phage 2023: Questions, Controversies, and What is Next? Targeting Phage…
Uncategorized Regulatory pathway needs to be developed to make the most of phages 8 Feb 2023 A regulatory pathway needs to be developed if the UK is to reap the benefits of bacteriophage therapy, Applied Microbiology International (AMI) has warned. France, Belgium and Poland are already…
Uncategorized Publish in this special issue to communicate your phage research 4 Feb 2023 A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Microbiology". Deadline for manuscript submissions: 12 May 2023 Special Issue "Bacteriophages: Infection, Genetics and Therapy" https://www.mdpi.com/journal/life/special_issues/196IPXRO2G Dear Colleagues, Bacteriophages…
Uncategorized The dynamic interplay of bacteriophage, bacteria and the mammalian host 31 Jan 2023 Title: "The dynamic interplay of bacteriophage, bacteria and the mammalian host during phage therapy" AbstractFor decades, biomedically-centered studies of bacteria have focused on mechanistic drivers of disease in their mammalian…
Uncategorized Personalized Inhaled Bacteriophage Therapy Decreases MDR P. aeruginosa 29 Jan 2023 In this fantastic work, Chan and colleagues show that using phage to treat P. aeruginosa lung infections in people with cystic fibrosis can lower P. aeruginosa levels, improve lung function, and drive…
Uncategorized PhageDiag project received grants from the EIC Accelerator Fund 28 Jan 2023 Vésale Bioscience, a research and development company of solutions and treatments using phage therapy for multi-resistant infections, has announced it has received €1.8m (£1.6m) in grants from the European Innovation Council…
Uncategorized First-in-human application of double-stranded RNA bacteriophage 20 Jan 2023 Publication: Brief Report - "First-in-human application of double-stranded RNA bacteriophage in the treatment of pulmonary Pseudomonas aeruginosa infection" by Li et al. https://doi.org/10.1111/1751-7915.14217 Abstract A double-stranded RNA (dsRNA) phage phiYY is able…
Uncategorized Adaptive Phage Therapeutics Announces First Patient Dosed in the PHAGE Clinical Trial 18 Jan 2023 Adaptive Phage Therapeutics, Inc., (APT) a clinical-stage biotechnology company advancing the APT phage bank, the world’s largest therapeutic phage initiative for treatment of bacterial infectious diseases, today announced the first…
Uncategorized Are bacteriophages the new antibiotics? 4 Jan 2023 Bacteriophages, viruses that infect bacteria, may be used as an alternative treatment option when antibiotics fail. Leiden researchers have studied the structure and function of a novel bacteriophage that could…